This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / UniQure Securities Fraud Class Action
Business class action lawsuit

UniQure Securities Fraud Class Action

Analysis based on 20 articles · First reported Apr 02, 2026 · Last updated Apr 13, 2026

Sentiment
-50
Attention
4
Articles
20
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market is impacted by the uncertainty surrounding UniQure's drug development and regulatory approval process, leading to potential stock price volatility. The class action lawsuit by Rosen Law Firm and The Schall Law Firm could result in significant financial liabilities for UniQure, affecting investor confidence and potentially leading to a decline in its stock value.

Biotechnology Legal Services
Event Summary

UniQure, a publicly traded company, is facing a class action lawsuit filed by Rosen Law Firm and The Schall Law Firm. The lawsuit alleges that UniQure made false and misleading statements to investors between September 24, 2025, and October 31, 2025. Specifically, UniQure is accused of failing to secure full United States — Food and Drug Administration approval for its Pivotal Study and downplaying the likelihood of delaying its Biologics License Application timeline to supplement data. Investors who purchased UniQure securities during this period are encouraged to join the lawsuit before the April 13, 2026, lead plaintiff deadline. Attorneys Philip Kim and Lawrence Rosen from Rosen Law Firm, and Brian Schall from The Schall Law Firm, are leading the efforts to represent affected shareholders.

Entities Involved
stock
UniQure
UniQure is facing a class action lawsuit for allegedly making false and misleading statements regarding the FDA approval of its Pivotal Study and the potential delay in its Biologics License Application timeline.
Importance 100.0 Sentiment -75.0
priv
Rosen Law Firm
Importance 0.0 Sentiment 0.0
per
Philip Kim
Importance 0.0 Sentiment 0.0
per
Lawrence Rosen
Importance 0.0 Sentiment 0.0
priv
The Schall Law Firm
Importance 0.0 Sentiment 0.0
per
Brian Schall
Importance 0.0 Sentiment 0.0
govactor
United States — United States Securities and Exchange Commission
Importance 0.0 Sentiment 0.0
govactor
United States — Food and Drug Administration
Importance 0.0 Sentiment 0.0
Relationships
UniQure related ↔ United States — Food and Drug Administration
Rosen Law Firm related ↔ Philip Kim
Rosen Law Firm related ↔ Lawrence Rosen
Rosen Law Firm competitor ↔ The Schall Law Firm Rosen Law Firm operates as a direct competitor to The Schall Law Firm, with both practices frequently competing to repre
Rosen Law Firm related ↔ Brian Schall
Rosen Law Firm none ↔ United States — United States Securities and Exchange Commission Rosen Law Firm has no direct structural or regulatory relationship with the SEC. The firm's connection to the agency is
Rosen Law Firm related ↔ United States — Food and Drug Administration
Philip Kim attorney ↔ Lawrence Rosen Philip Kim is an attorney at the Rosen Law Firm, working under the direction of founding partner Lawrence Rosen. Kim fre
Philip Kim peer ↔ The Schall Law Firm Philip Kim is an attorney at Rosen Law Firm, which operates in the same shareholder litigation space as The Schall Law F
Philip Kim competitor ↔ Brian Schall Philip Kim is an attorney at Rosen Law Firm who regularly competes against Brian Schall for clients in major securities
Philip Kim unaffiliated ↔ United States — United States Securities and Exchange Commission Philip Kim is a private attorney whose securities class action lawsuits cite SEC regulations, but he holds no direct rel
Philip Kim related ↔ United States — Food and Drug Administration
Lawrence Rosen none ↔ The Schall Law Firm Lawrence Rosen has no direct relationship with The Schall Law Firm; he is the founding partner of Rosen Law Firm, a sepa
Lawrence Rosen competitor ↔ Brian Schall Lawrence Rosen is a professional peer and competitor to Brian Schall, as both men direct competing law firms that routin
Lawrence Rosen securities lawyer ↔ United States — United States Securities and Exchange Commission Lawrence Rosen is a founding partner of the Rosen Law Firm, a private legal practice that litigates class action lawsuit
+ 7 more relationships View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.